{
  "meta": {
    "title": "56_Pharmacology_Neet_2022",
    "url": "https://brainandscalpel.vercel.app/56-pharmacology-neet-2022-15a432be.html",
    "scrapedAt": "2025-11-30T12:58:09.302Z"
  },
  "questions": [
    {
      "text": "A male patient with chronic obstructive pulmonary disease (COPD) was prescribed theophylline. He noticed that his urine output had increased the following day. This action of the drug is mediated through which of the following receptors?",
      "choices": [
        {
          "id": 1,
          "text": "Interleukin-10"
        },
        {
          "id": 2,
          "text": "Histone deacetylase"
        },
        {
          "id": 3,
          "text": "Adenosine A1"
        },
        {
          "id": 4,
          "text": "Beta 2 adrenergic receptors"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>An <strong>increased urine output</strong> after administering <strong>theophylline</strong> is due to the <strong>antagonism</strong> at <strong>adenosine A1 receptors.</strong></p>\n<p>The <strong>adenosine A1</strong> receptors are present in the <strong>afferent arteriole</strong> of the <strong>glomeruli.</strong> When <strong>activated,</strong> they cause&nbsp;<strong>vasoconstriction</strong> that&nbsp;<strong>reduces</strong> the glomerular filtration rate (GFR) and renal blood flow. This reduces <strong>urine output.</strong> Antagonistic action on these receptors will cause an increased GFR and renal blood flow and hence increased urine output.</p>\n<p>Methylxanthines like theophylline and aminophylline are the <strong>bronchodilators</strong> used mainly in chronic obstructive pulmonary disease (<strong>COPD</strong>) and bronchial asthma. The pharmacological actions of theophylline are:</p>\n<ul>\n<li>It&nbsp;<strong>inhibits&nbsp;phosphodiesterase (PDE) </strong>non-selectively, thereby increasing cellular cAMP and cGMP,&nbsp;causing <strong>bronchodilation.&nbsp;</strong></li>\n<li>Adenosine causes bronchoconstriction by releasing histamine and leukotrienes. Theophylline <strong>antagonizes adenosine A1 receptors</strong> and causes <strong>bronchodilation.</strong></li>\n<li>It <strong>increases IL-10</strong> release, which has&nbsp;<strong>anti-inflammatory</strong> actions.</li>\n<li>It causes a&nbsp;<strong>decrease</strong> in gene transcription of <strong>pro-inflammatory cytokines.</strong></li>\n<li>It <strong>promotes apoptosis</strong> of<strong> granulocytes</strong> and thereby, <strong>reduces</strong> the <strong>inflammatory</strong> load in the airways.</li>\n</ul>\n<p><strong>Adverse effects</strong> of theophylline:</p>\n<ul>\n<li>Headache, nausea, and vomiting (due to inhibition of PDE4)</li>\n<li>Increased acid secretion (due to PDE inhibition)</li>\n<li><strong>Diuresis</strong> (due to inhibition of <strong>adenosine A1</strong> receptors)</li>\n<li>Cardiac arrhythmias (due to inhibition of cardiac <strong>PDE3</strong> and antagonism of <strong>cardiac A1 receptors</strong>).</li>\n<li>Seizures (due to central A1 receptor antagonism).</li>\n</ul>\n<p>Theophylline is mainly metabolized mainly by the enzyme <strong>CYP1A2. </strong>Therefore, it has various<strong> drug interactions, </strong>which include:</p>\n<ol>\n<li>Agents that lower its plasma level are&nbsp;<strong>smoking,</strong> phenytoin, <strong>rifampicin</strong>, and phenobarbitone.</li>\n<li>Drugs that increase its plasma level are erythromycin, ciprofloxacin, <strong>oral contraceptives</strong>, and allopurinol.</li>\n</ol><hr><h3>Related Pearl: PDE inhibitors</h3><table>\n<tbody>\n<tr>\n<td><span><strong>PDE inhibitors</strong></span></td>\n<td><span><strong>Drugs</strong></span></td>\n<td><span><strong>Clinical application</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Non-selective PDE inhibitors</strong></span></p>\n<p><span><strong>&nbsp;</strong></span></p>\n</td>\n<td>\n<p><span>Methylated xanthines, Caffeine, Theophylline</span></p>\n</td>\n<td>\n<p><span>Asthma, COPD</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>&nbsp;</strong></span></td>\n<td>\n<p><span>Pentoxifylline</span></p>\n</td>\n<td>\n<p><span>Peripheral artery disease &nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>PDE 2 inhibitor</strong></span></td>\n<td>\n<p><span>Anagrelide</span></p>\n</td>\n<td><span>Essential thrombocytosis</span></td>\n</tr>\n<tr>\n<td><span><strong>PDE 3 inhibitor</strong></span></td>\n<td>\n<p><span>Cilostazol</span></p>\n</td>\n<td><span>Peripheral artery disease</span></td>\n</tr>\n<tr>\n<td><span><strong>&nbsp;</strong></span></td>\n<td>\n<p><span>Milrinone, Amrinone</span></p>\n</td>\n<td><span>Cardiac failure&nbsp;&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>PDE 4 inhibitor</strong></span></td>\n<td>\n<p><span>Roflumilast</span></p>\n</td>\n<td><span>COPD</span></td>\n</tr>\n<tr>\n<td><span><strong>&nbsp;</strong></span></td>\n<td>\n<p><span>Drotaverine</span></p>\n</td>\n<td><span>Antispasmodic drug</span></td>\n</tr>\n<tr>\n<td><span><strong>PDE 5 inhibitor</strong></span></td>\n<td>\n<p><span>Sildenafil, Vardenafil, Tadalafil (Also inhibit PDE6)</span></p>\n</td>\n<td><span>Erectile dysfunction Pulmonary hypertension</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span>&nbsp;</span></p><hr><h3>Related Pearl: Drugs which need Therapeutic Drug Monitoring (TDM)</h3><p>Drugs with a narrow therapeutic index require therapeutic drug monitoring (TDM).</p>\n<p>The mnemonic \"<strong>DATLAAT MC</strong>\" can be used.</p>\n<ul>\n<li><strong>D</strong>: Digoxin</li>\n<li><strong>A</strong>: Anti-arrhythmic</li>\n<li><strong>T</strong>: Theophylline</li>\n<li><strong>L</strong>: Lithium</li>\n<li><strong>A</strong>: Aminoglycosides</li>\n<li><strong>A</strong>: Anti-epileptics</li>\n<li><strong>T</strong>: Tricyclic antidepressants</li>\n<li><strong>M</strong>: Methotrexate</li>\n<li><strong>C</strong>: Calcineurin inhibitors</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5143",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following drugs is not likely to cause a pleural pathology?",
      "choices": [
        {
          "id": 1,
          "text": "Metformin"
        },
        {
          "id": 2,
          "text": "Methysergide"
        },
        {
          "id": 3,
          "text": "Bleomycin"
        },
        {
          "id": 4,
          "text": "Nitrofurantoin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Metformin is not associated with pleural pathology.</p>\n<p>Metformin belongs to the <strong>biguanides</strong> class of oral hypoglycemic agents. It acts by activation of AMP-dependent protein kinase (<strong>AMPK</strong>). This results in reduced hepatic glucose production.</p>\n<p><strong>Side effects</strong> of <strong>metformin</strong> are <strong>l</strong><strong>actic acidosis, </strong>gastrointestinal disturbance, and <strong>vitamin B12 deficiency.</strong></p>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p><strong>Contraindications</strong> for <strong>metformin</strong> include :</p>\n<ul>\n<li><strong>GFR &lt;30 ml/min</strong></li>\n<li>Unstable CHF</li>\n<li>Radiographic contrast studies</li>\n<li>Hospitalized patients who cannot take anything orally</li>\n<li>Acidosis</li>\n</ul>\n<p>Other options:</p>\n<p>Option B: <strong>Methysergide</strong> is a serotonin(<strong>5-HT</strong>) receptor antagonist. It was used for the treatment of <strong>migraine prophylaxis</strong> and carcinoid syndrome. But its use has been discontinued due to side effects like abdominal, <strong>pulmonary</strong> and endocardial <strong>fibrosis</strong>.</p>\n<p>Option C: <strong>Bleomycin </strong>is an anticancer antibiotic used for the treatment of squamous cell cancer and Hodgkin lymphoma. It chelates copper or iron and produces superoxide ions that damage DNA. Side effects are mucocutaneous toxicity and <strong>pulmonary fibrosis.</strong></p>\n<p>Option D: <strong>Nitrofurantoin</strong> is a urinary antiseptic. They are used for the treatment of lower urinary tract infections (<strong>UTIs</strong>). It acts by <strong>damaging DNA</strong> and inhibiting protein synthesis in susceptible bacteria. Important side effects are gastrointestinal disturbances, liver damage and <strong>pulmonary fibrosis</strong>.</p>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5226",
      "difficulty": "easy"
    },
    {
      "text": "A patient with deep vein thrombosis was started on a new drug. After 2 days, he presented with the given finding. Which of the following drugs is implicated in causing the above condition?",
      "choices": [
        {
          "id": 1,
          "text": "Warfarin"
        },
        {
          "id": 2,
          "text": "Heparin"
        },
        {
          "id": 3,
          "text": "Dabigatran"
        },
        {
          "id": 4,
          "text": "Rivaroxaban"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical scenario of the development of <strong>purple toe syndrome,</strong> after starting a new drug for the treatment of deep vein thrombosis, is suggestive of the adverse effect of <strong>warfarin</strong>.</p>\n<div>Purple toe syndrome is a rare complication of warfarin therapy. It occurs due to <strong>cholesterol microemboli</strong> released from atheromatous plaques, which cause <strong>arteriolar occlusion.</strong> Warfarin must be immediately stopped and replaced with an <strong>oral</strong> factor <strong>Xa inhibitor</strong> (e.g. apixaban).</div>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p><strong>Activation</strong> of <strong>coagulation factors II, VII, IX,</strong> and <strong>X</strong> and proteins C and S are done by <strong>carboxylation</strong> of their glutamate residues, with the help of the reduced form of <strong>vitamin</strong> <strong>K</strong> as a co-factor. This reduced form of vitamin K needs to be constantly recycled back from its oxidized form for the reaction to continue. This recycling is done by the enzyme&nbsp;<strong>vitamin K epoxide reductase,&nbsp;</strong>which&nbsp;is&nbsp;<strong>competitively</strong>&nbsp;<strong>inhibited by warfarin</strong>. Hence, there will be a reduction in the activation of coagulation factors.</p>\n<p>The image below shows warfarin's mechanism of action.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2bc835721e6e4ef99b01e279efaeada3x1279x1234.JPEG\" alt=\"Explanation Image\"><div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>The half-life of <strong>proteins C</strong> and <strong>S</strong> are 8 and 24 hours, respectively, which is relatively <strong>shorter </strong>than the half-lives of other clotting factors, particularly factor II. Therefore, the full antithrombotic effect of warfarin is not achieved for <strong>4 to 5 days</strong>. For this reason, warfarin must be bridged with a rapidly acting parenteral anticoagulant, such as <strong>heparin</strong>, low-molecular-weight heparin (<strong>LMWH</strong>), or fondaparinux, in patients with thrombosis or at high risk for thrombosis.</p>\n<p>Uses of warfarin are acute deep vein thrombosis, pulmonary embolism, and <strong>p</strong><strong>reventing stroke </strong>or <strong>systemic embolization</strong> in patients with a <strong>mechanical heart valve</strong>.&nbsp;</p>\n<p>Adverse effects of warfarin are bleeding, skin necrosis, <strong>p</strong><strong>urple toe syndrome,</strong>&nbsp;and&nbsp;<strong>f</strong><strong>etal warfarin syndrome</strong>&nbsp;(hypoplasia of the nose, eye socket, hand bones, and growth retardation).</p>\n<p>The therapeutic dose of warfarin is monitored by an <strong>INR</strong> range of <strong>2-3</strong>. Warfarin toxicity&nbsp;can occur when the INR exceeds <strong>4</strong> and can lead to <strong>fatal bleeding</strong>. Treatment includes withholding warfarin, with&nbsp;<strong>v</strong><strong>itamin K,</strong> and <strong>b</strong><strong>lood transfusions </strong>or <strong>fresh frozen plasma</strong> to replenish clotting factors.</p>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>Warfarin, LMWH, and UFH <strong>do not</strong> accumulate in breast milk and do not have an anticoagulant effect in the newborn. They are <strong>compatible</strong> with breastfeeding.</p>\n<p><strong><span data-preserver-spaces=\"true\">Warfarin</span></strong><span data-preserver-spaces=\"true\">&nbsp;is mainly&nbsp;</span><strong><span data-preserver-spaces=\"true\">metabolized&nbsp;</span></strong><span data-preserver-spaces=\"true\">by the</span><strong><span data-preserver-spaces=\"true\">&nbsp;CYP2C9</span></strong><span data-preserver-spaces=\"true\">&nbsp;enzyme. Drugs that affect the <strong>CYP2C9</strong> enzyme can alter the anticoagulant function of warfarin and these include the following: </span></p>\n<p><span data-preserver-spaces=\"true\">Reduced efficacy:</span></p>\n<ul>\n<li><span data-preserver-spaces=\"true\">CYP2C9 activation by drugs: barbiturates, carbamazepine, rifampin</span></li>\n<li><span data-preserver-spaces=\"true\">Oral contraceptives: increase blood levels of clotting factors</span></li>\n</ul>\n<p><span data-preserver-spaces=\"true\">Increased efficacy:</span></p>\n<ul>\n<li><span data-preserver-spaces=\"true\">Drugs causing CYP2C9 inhibition:</span></li>\n<ul>\n<li class=\"ql-indent-1\"><span data-preserver-spaces=\"true\">Amiodarone</span></li>\n<li class=\"ql-indent-1\"><span data-preserver-spaces=\"true\">Azole antifungals</span></li>\n<li class=\"ql-indent-1\"><span data-preserver-spaces=\"true\">Cimetidine</span></li>\n<li class=\"ql-indent-1\"><span data-preserver-spaces=\"true\">Clopidogrel</span></li>\n<li class=\"ql-indent-1\">Cotrimoxazole</li>\n<li class=\"ql-indent-1\"><span data-preserver-spaces=\"true\">Disulfiram</span></li>\n<li class=\"ql-indent-1\"><span data-preserver-spaces=\"true\">Isoniazid</span></li>\n<li class=\"ql-indent-1\"><strong>Metronidazole</strong></li>\n<li class=\"ql-indent-1\"><span data-preserver-spaces=\"true\">Fluoxetine</span></li>\n<li class=\"ql-indent-1\"><span data-preserver-spaces=\"true\">Sulfinpyrazone</span></li>\n<li class=\"ql-indent-1\"><span data-preserver-spaces=\"true\">Zafirlukast</span></li>\n</ul>\n</ul>\n<p><span data-preserver-spaces=\"true\">Other options:</span></p>\n<p><span data-preserver-spaces=\"true\">Option B: <strong><span class=\"col\">Heparin </span></strong><span class=\"col\">acts by activating antithrombin III, thereby inactivating the active form of clotting factors II, IX, X, XI, XII, and XIII. Adverse effects are bleeding and <strong>heparin-induced thrombocytopenia</strong> (HIT) due to the formation of antibodies against the heparin-platelet complex.</span></span></p>\n<p><span data-preserver-spaces=\"true\">Option C: <strong><span class=\"col\">Dabigatran </span></strong><span class=\"col\">is a direct thrombin inhibitor. It is used for the prevention of embolism and stroke in patients with atrial fibrillatio</span>n. <strong>Bleeding</strong> and <strong>dyspepsia</strong> are the most important adverse effects.</span></p>\n<p><span data-preserver-spaces=\"true\">Option D: <strong><span class=\"col\">Rivaroxaban </span></strong><span class=\"col\">is a </span><span class=\"col\">direct inhibitor of factor Xa. It is used for prophylaxis and treatment of deep vein thrombosis. Side effects reported are bleeding, nausea, hypotension, tachycardia, and edema.</span></span></p>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Classification of Anticoagulants</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b14dd7e06cd44c95a1d5289e3a32ad8ax1280x1944.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Classification of anticoagulants</strong></td>\n</tr>\n<tr>\n<td>1) Vitamin K antagonist</td>\n<td>Warfarin</td>\n</tr>\n<tr>\n<td>2) Direct thrombin inhibitors (DTI)&nbsp;&nbsp;&nbsp;</td>\n<td>\n<p><strong>Parenteral:&nbsp;Monovalent</strong> DTI-&nbsp;Argatroban</p>\n<p><strong>Bivalent</strong> DTI- Lepirudin, Desirudin, Bivalirudin</p>\n<p><strong>Oral</strong>:&nbsp;Dabigatran&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>3) Indirect thrombin inhibitors&nbsp;</td>\n<td>\n<p>Unfractionated heparin</p>\n<p>Low molecular weight heparins:&nbsp;Enoxaparin, Dalteparin, Tinzaparin, Nadroparin</p>\n</td>\n</tr>\n<tr>\n<td>4) Indirect factor Xa inhibitors</td>\n<td>Fondaparinux</td>\n</tr>\n<tr>\n<td>5) <strong>Oral</strong> Direct factor Xa inhibitors</td>\n<td>Rivaro<strong>xa</strong>ban,Api<strong>xa</strong>ban, Edo<strong>xa</strong>ban,Betri<strong>xa</strong>ban</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Specific reversal agents for anticoagulants</h3><ul>\n<li>Heparin: protamine sulfate </li>\n<li>Warfarin: vitamin K </li>\n<li>Rivaroxaban and other oral Xa inhibitors: andexanet alfa </li>\n<li>Dabigatran: idarucizumab</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/842afb9681c443a99e97961fcb6d416f.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5315",
      "difficulty": "easy"
    },
    {
      "text": "A patient undergoing chemotherapy was given an antiemetic, after which he developed symptoms like acute dystonia, bradykinesia, and tremors. Which of the following drugs would have caused these symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Ondansetron"
        },
        {
          "id": 2,
          "text": "Metoclopramide"
        },
        {
          "id": 3,
          "text": "Meclizine"
        },
        {
          "id": 4,
          "text": "Scopolamine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the above scenario, the patient has developed&nbsp;<strong>extrapyramidal</strong> adverse effects like <strong>acute dystonia,</strong> <strong>bradykinesia</strong>, and<strong> tremors. </strong>This is likely due to<strong>&nbsp;</strong>the&nbsp;<strong>antagonist</strong> action on <strong>dopamine receptors</strong> by <strong>metoclopramide.</strong></p>\n<p>Metoclopramide is a <strong>prokinetic</strong> and <strong>antiemetic.</strong> It has the following <strong>pharmacological actions:</strong></p>\n<ul>\n<li><strong>Dopamine</strong> receptor <strong>antagonist</strong>&nbsp;</li>\n<li>Serotonin (<strong>5HT4</strong>) receptor <strong>agonist</strong>&nbsp;</li>\n<li>Serotonin (<strong>5HT3</strong>) <strong>antagonist</strong></li>\n<li><strong>Sensitization</strong> of <strong>muscarinic receptors</strong> on <strong>smooth muscle.</strong> This results in <strong>increased</strong> lower <strong>esophageal sphincter tone</strong> and stimulates gastric antral contractions.</li>\n</ul>\n<p>Metoclopramide acts on both the gastrointestinal system and central nervous system. It is used as an upper antiemetic for many types of vomiting, especially migraine, drug-induced, and<strong> chemotherapy-induced</strong>. It is also used as a prokinetic in <strong>gastroparesis</strong> to increase gastric emptying.</p>\n<p>Adverse effects of metoclopramide are mainly extrapyramidal effects, and these include <strong>acute dystonia, Parkinson</strong><strong>-like</strong> symptoms (tremors, bradykinesia, rigidity), tardive dyskinesia,<strong> galactorrhea </strong>due to hyperprolactinemia, and methemoglobinemia in neonates.</p>\n<p>Extrapyramidal symptoms can be <strong>treated</strong> by <strong>discontinuation</strong> of metoclopramide and administration of anticholinergics or antihistaminics.</p>\n<p>Other options:</p>\n<p>Option A: <span data-preserver-spaces=\"true\">Ondansetron is a</span><strong><span data-preserver-spaces=\"true\">&nbsp;5-HT<sub>3</sub> receptor antagonist</span></strong>. It blocks impulses at the peripheral origin in GIT. <span data-preserver-spaces=\"true\">It is most commonly indicated for the treatment of&nbsp;</span><strong><span data-preserver-spaces=\"true\">postoperative&nbsp;</span></strong><span data-preserver-spaces=\"true\">and <strong>chemotherapy</strong>-<strong>induced</strong></span><strong><span data-preserver-spaces=\"true\">&nbsp;nausea </span></strong>and <strong><span data-preserver-spaces=\"true\">vomiting. </span></strong><span data-preserver-spaces=\"true\">Headache and dizziness are the common adverse effects.<br /></span></p>\n<p>Option C:<strong> Meclizine</strong> is a&nbsp;long-acting <strong>H1 antihistaminic</strong> drug.&nbsp;It is used for <strong>seasickness</strong>. It is less sedative and less anticholinergic.</p>\n<p>Option D: <strong>Scopolamine (hyoscine)</strong> is a <strong>muscarinic antagonist.</strong> It blocks neural pathways from the vestibular apparatus in the inner ear to the emetic center in the brainstem. A <strong>transdermal patch</strong> of scopolamine is used as an antiemetic in <strong>motion sickness</strong>. Constipation, drowsiness, dry mouth, and blurred vision are the common adverse effects.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5142",
      "difficulty": "easy"
    },
    {
      "text": "A young patient started to take a weight loss medication that acts by inhibiting fat absorption from food. After a few weeks, she developed easy bruising and increased menstrual bleeding. Deficiency of which of the following vitamins is responsible for her condition?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin E"
        },
        {
          "id": 2,
          "text": "Vitamin K"
        },
        {
          "id": 3,
          "text": "Vitamin B6"
        },
        {
          "id": 4,
          "text": "Vitamin D"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical scenario of <strong>easy bruising</strong> and <strong>increased menstrual bleeding</strong> following weight loss medication that inhibits fat absorption from food is suggestive of <strong>vitamin</strong> <strong>K</strong> <strong>deficiency</strong>.</p>\n<p>Vitamin K is a <strong>fat-soluble</strong> vitamin. Hence, drugs that inhibit the absorption of fat (eg; <strong>ezetimibe</strong>) also inhibit the absorption of fat-soluble vitamin K. The following are the vitamers of vitamin K:</p>\n<div class=\"page\" title=\"Page 2363\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li aria-level=\"1\"><strong>Phylloquinone</strong> (Vitamin <strong>K1</strong>) is the normal dietary source of Vitamin K that is found in green vegetables.</li>\n<li aria-level=\"1\"><strong>Menaquinone</strong> (Vitamin <strong>K2</strong>) is synthesized by intestinal bacteria.</li>\n<li aria-level=\"1\"><strong>Menadione</strong> (Vitamin <strong>K3</strong>) is a synthetic compound that is metabolized to phylloquinone.</li>\n</ul>\n</div>\n</div>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Vitamin K is required for <strong>γ-</strong><strong>carboxylation</strong> of glutamate residues of clotting factors like <strong>prothrombin</strong> (factor <strong>II</strong>), factors <strong>VII, IX,</strong> and <strong>X</strong>. Warfarin inhibits γ-carboxylation by preventing the conversion of vitamin K to its active hydroquinone form.</p>\n<div class=\"page\" title=\"Page 2363\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Vitamin K deficiency in adults may be seen in patients with liver disease, obstructive jaundice, malabsorption, and prolonged antimicrobial therapy. Vitamin K <strong>deficiency</strong> is usually <strong>diagnosed</strong> on the basis of an <strong>elevated prothrombin time</strong> or <strong>reduced clotting factors. </strong></p>\n<p>Vitamin K deficiency is <strong>treated</strong> with a <strong>parenteral</strong> dose of <strong>10 mg</strong> followed by 5mg (duration depends on the severity of vitamin K deficiency).</p>\n<p>Other options:</p>\n<p>Option A: <strong>Vitamin</strong> <strong>E </strong>is a fat-soluble vitamin. The levels of vitamin E also will get decreased following taking weight loss medication that inhibits fat absorption from food. But the symptoms of vitamin E deficiency include <strong>hemolytic anemia</strong> and neuromuscular manifestations.</p>\n<p>Option C: <strong> Vitamin B6 </strong>is a water-soluble vitamin. Drugs that cause vitamin B6 deficiency are isoniazid, hydralazine, cycloserine, penicillamine, and oral contraceptives. Patients usually present with <strong>peripheral neuritis,</strong> anemia, seborrheic dermatitis, glossitis, lowered seizure threshold, or convulsions (due to fall in brain GABA levels).</p>\n<p>Option D: <strong>Vitamin</strong> <strong>D </strong>is a fat-soluble vitamin. Vitamin D levels will also decrease following weight loss medication that inhibits fat absorption from food. Patients with vitamin D deficiency will typically develop <strong>rickets</strong> in children and <strong>osteomalacia</strong> in adults.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5390",
      "difficulty": "easy"
    },
    {
      "text": "A woman presenting with symptoms of urinary tract infection was prescribed a drug that causes tendon rupture and arthropathy. What is the mechanism of action of the drug?",
      "choices": [
        {
          "id": 1,
          "text": "DNA gyrase inhibition"
        },
        {
          "id": 2,
          "text": "Ribosomal inhibition"
        },
        {
          "id": 3,
          "text": "Cell wall synthesis inhibition"
        },
        {
          "id": 4,
          "text": "Inhibition of folic acid synthesis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the above scenario, the antimicrobial prescribed for <strong>urinary tract infection,</strong> which has a propensity to cause <strong>tendon rupture</strong> and <strong>arthropathy</strong>, is likely to be a <strong>fluoroquinolone</strong>. The mechanism of action of the drug is <strong>DNA gyrase inhibition.</strong></p>\n<p>Normally, during replication, to prevent excessive positive supercoiling of the strands, <strong>DNA gyrase</strong> nicks double-stranded DNA and introduces <strong>negative supercoils.&nbsp;</strong>Fluoroquinolones, by inhibiting DNA gyrase (in <strong>gram-negative</strong> bacteria), result in the production of damaged DNA. This is finally digested by exonucleases, resulting in <strong>bactericidal action.</strong></p>\n<p>Fluoroquinolones inhibit&nbsp;<strong>topoisomerase IV</strong> in <strong>gram-positive</strong> bacteria.</p>\n<p>Fluoroquinolones are used in the treatment of <strong>urinary tract infections</strong>, prostatitis, and gastrointestinal, respiratory infections, and as a&nbsp;<strong>second-line</strong> drug in <strong>anti-tubercular therapy</strong>. They are <strong>avoided</strong> in <strong>children</strong> and <strong>pregnant women</strong>.</p>\n<p>Adverse effects of fluoroquinolones are <strong>arthralgia, t</strong><strong>endon rupture, </strong><em>Clostridium difficile</em> colitis, dysglycemia, prolonged QT interval, rashes, hallucinations, delirium, and seizures.</p>\n<p>Other options:</p>\n<p>Option B: <strong>Ribosomal inhibition</strong> is the mechanism of action of various antimicrobials like <strong>tetracyclines, aminoglycosides, chloramphenicol, and macrolides</strong>.</p>\n<p>Option C: <strong>Cell wall synthesis inhibition</strong> is done by <strong>beta-lactam antibiotics</strong>.</p>\n<p>Option D: <strong>Inhibition of folic acid synthesis</strong> is the mechanism of action of <strong>sulfonamides</strong> and <strong>co-trimoxazole</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5144",
      "difficulty": "medium"
    },
    {
      "text": "A patient was brought to the emergency with a history of consumption of 8 tablets of digoxin. On examination, he was unstable and his heart rate was 56 bpm. ECG showed a 3rd-degree heart block. What is the next step in the management of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Antibody against digoxin"
        },
        {
          "id": 2,
          "text": "Lidocaine"
        },
        {
          "id": 3,
          "text": "DC cardioversion"
        },
        {
          "id": 4,
          "text": "Phenytoin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Administration of <strong>digibind</strong> (<strong>antibody against digoxin</strong>) is the next step in managing this patient. An <strong>unstable</strong> patient with <strong>bradycardia</strong> and <strong>3rd-degree</strong> heart block following <strong>digoxin toxicity</strong> should be treated with digibind.</p>\n<p><strong>Digibind</strong> is a nonimmunogenic antibody used to treat cardiotoxicity due to digoxin. It is <strong>nonimmunogenic</strong> because it <strong>lacks</strong> the <strong>Fc</strong> fragment.</p>\n<p><strong>Digoxin</strong> is the cardiac glycoside used to <strong>treat heart failure</strong> and control ventricular rate in <strong>atrial fibrillation/flutter.</strong></p>\n<p>It <strong>inhibits</strong> <strong>Na<sup>+</sup>/K<sup>+ </sup>ATPase</strong>, a membrane-bound transporter to increase intracellular sodium. As a result, there is less expulsion of calcium from the cell by the sodium-calcium exchanger (<strong>NCX). Increased calcium</strong> inside the myocyte leads to<strong> </strong>an<strong> increase </strong>in cardiac <strong>contractility.</strong></p>\n<p>The most common cardiac manifestations of digitalis toxicity are <strong>ventricular tachycardia,</strong> partial to <strong>complete A-V block</strong>, <strong>severe bradycardia</strong>, and atrial fibrillation/flutter.</p>\n<p>Factors that <strong>increase</strong> the <strong>risk</strong> of digoxin <strong>toxicity</strong> are:</p>\n<ul>\n<li><strong>Hypokalemia</strong></li>\n<li><strong>Drugs</strong> that decrease digoxin elimination (<strong>inhibitors of P-glycoprotein</strong>) like <strong>quinidine</strong></li>\n<li>Renal/hepatic failure</li>\n<li>Thyrotoxicosis</li>\n</ul>\n<p>Option B: <strong>Lidocaine</strong> is commonly used as a local anesthetic. It has <strong>anti-arrhythmic</strong> properties and is used to suppress<strong> ventricular tachycardia</strong> <strong>caused</strong> by <strong>digitalis toxicity</strong>.</p>\n<p>Option C: <strong>DC cardioversion</strong> is used for tachyarrythmias when pharmacologic treatment fails. It is not used in bradyarrhythmias.</p>\n<p>Option D: <strong>Phenytoin </strong>is an <strong>antiepileptic</strong> used for the treatment of generalized tonic-clonic seizures and partial seizures. It can also be used for the treatment of <strong>polymorphic ventricular tachycardia</strong> due to QT prolongation.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5193",
      "difficulty": "medium"
    },
    {
      "text": "An elderly man, who is a known case of diabetic nephropathy, presented to the emergency with palpitations and chest discomfort. ECG showed tall T-waves. Laboratory investigations showed elevated potassium levels. Which of the following drugs will cause the shift of potassium back into the cell?",
      "choices": [
        {
          "id": 1,
          "text": "Epinephrine"
        },
        {
          "id": 2,
          "text": "Glucagon"
        },
        {
          "id": 3,
          "text": "Atropine"
        },
        {
          "id": 4,
          "text": "Lactic acid"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical scenario with&nbsp;ECG showing&nbsp;<strong>tall T-waves</strong> and elevated serum potassium levels are suggestive of <strong>hyperkalemia</strong>.&nbsp;<strong>Epinephrine</strong> will cause the <strong>shift</strong> of <strong>potassium</strong> <strong>back</strong> into the <strong>cell</strong>.</p>\n<p><strong>Epinephrine </strong>is an <strong>agonist</strong> at <strong>alpha 1, beta 1,&nbsp;</strong>and<strong> beta 2 </strong>receptors.</p>\n<p>The <strong>&beta; actions</strong> are mediated through <strong>cAMP</strong>. Epinephrine binds to <strong>Gs</strong> &rarr; ATP and is broken down to cAMP by the enzyme adenylyl cyclase. This results in:</p>\n<ul>\n<li>In the liver and muscle- hyperglycemia and <strong>hypokalemia</strong> due to potassium uptake in muscle and liver</li>\n<li>In adipose tissue- increased plasma free fatty acids</li>\n<li>In the heart- an increased force of contraction reinforces the positive inotropic action</li>\n<li>In pancreatic islets- increases glucagon secretion</li>\n</ul>\n<p>Epinephrine is used in&nbsp;anaphylaxis, to prolong the action of local anesthetics, cardiac arrest, and as inhalational epinephrine in the treatment of post-intubation and infectious <strong>croup</strong>.</p>\n<p>Epinephrine is <strong>contraindicated</strong> in <strong>anesthesia</strong> with <strong>halothane</strong> due to the <strong>risk</strong> of <strong>arrhythmias</strong> and in patients receiving <strong>beta-blockers</strong> because a <strong>marked rise</strong> in <strong>BP</strong> can occur due to unopposed alpha action.</p>\n<p><strong>Hyperkalemia</strong> refers to an increase in the levels of <strong>serum potassium</strong>&nbsp;<strong>&gt;5.5mEq/L. </strong></p>\n<p>The image given below shows sequential ECG changes seen in hyperkalemia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a1895eaf52fb4c3d8d913d05be51e13dx1279x1256.JPEG\" alt=\"Explanation Image\"><div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>Hyperkalemia is a medical emergency and has to be treated when ECG changes are present or severe hyperkalemia (serum K<sup>+</sup> &gt;6.5) without ECG changes. Management is as follows:</p>\n<ul>\n<li>Intravenous infusion of 10 ml of 10% <strong>calcium gluconate</strong> for 2-3 minutes with cardiac monitoring. It helps to antagonize the cardiac effects.</li>\n<li>Intravenous regular<strong> insulin</strong> 10 units followed by 50mL of 50 % <strong>dextrose</strong>. This helps in <strong>shifting</strong> the <strong>plasma</strong> <strong>K</strong><sup>+</sup> into the cells.</li>\n<li><strong>Nebulisation</strong> with&nbsp;<strong>&beta;<sub>2&nbsp;</sub>agonists</strong> such as albuterol or salbutamol.</li>\n<li><strong>Cation exchange resins</strong>, <strong>diuretics,</strong> and/or<strong> dialysis</strong> are useful to remove the excess potassium.&nbsp;</li>\n</ul>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5322",
      "difficulty": "medium"
    },
    {
      "text": "A patient with a pituitary tumor that overproduced growth hormone underwent surgical removal of the tumor. The resection was found to be incomplete. What is the first-line treatment for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Leuprolide"
        },
        {
          "id": 2,
          "text": "Goserelin"
        },
        {
          "id": 3,
          "text": "Nafarelin"
        },
        {
          "id": 4,
          "text": "Octreotide"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The above scenario with a <strong>pituitary tumor</strong> producing <strong>growth hormone</strong> is likely to cause&nbsp;<strong>acromegaly&nbsp;</strong>in the patient. <strong>Octreotide</strong> is the <strong>first-line</strong> treatment for this condition.</p>\n<p>Octreotide is a <strong>synthetic analog</strong> of<strong> somatostatin</strong>.</p>\n<p>Octreotide can be used in the following conditions:</p>\n<ul>\n<li><strong>Acromegaly </strong></li>\n<li><strong>Secretory diarrheas</strong> associated with carcinoid, AIDS, cancer chemotherapy, or diabetes- by suppression of hormones that enhance intestinal mucosal secretion.</li>\n<li><strong>Bleeding</strong> esophageal<strong> varices-</strong>&nbsp;reduces hepatic blood flow and helps stop bleeding.</li>\n<li><strong>Dumping syndrome</strong> in post gastric surgery patients</li>\n</ul>\n<p><strong>Adverse effects</strong> of octreotide are:</p>\n<ul>\n<li>Abdominal pain</li>\n<li>Nausea</li>\n<li><strong>Steatorrhea</strong></li>\n<li><strong>Gall stones</strong> (due to biliary stasis)</li>\n<li>Hyperglycemia</li>\n</ul>\n<p>Other options:</p>\n<p>Option A: <strong>Leuprolide</strong> is a long-acting GnRH agonist. It is used for palliation of <strong>carcinoma prostate,</strong> uterine fibroids, endometriosis, and precocious puberty. Side effects include hot flashes, decreased bone mineral density, vaginal dryness, and erectile dysfunction.</p>\n<p>Option B: <strong>Goserelin</strong> is also a GnRH agonist used for the treatment of <strong>endometriosis,</strong> dysfunctional uterine bleeding, and for prostate and breast cancer.</p>\n<p>Option C: <strong>Nafarelin</strong> is a long-acting GnRH agonist. It is used for the treatment of endometriosis, uterine fibroids, and <strong>central precocious puberty.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5310",
      "difficulty": "easy"
    },
    {
      "text": "A middle-aged male patient presents with protrusion of the chin, excessive sweating, impaired glucose tolerance, and enlargement of hands and feet. Which of the following is a growth hormone receptor antagonist used to treat this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Octreotide"
        },
        {
          "id": 2,
          "text": "Pegvisomant"
        },
        {
          "id": 3,
          "text": "Cabergoline"
        },
        {
          "id": 4,
          "text": "Olcegepant"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical features of <strong>protrusion</strong> of the<strong> chin, excessive sweating, impaired glucose tolerance, </strong>and<strong> enlargement</strong> of<strong> hands</strong> and<strong> feet</strong> are suggestive of <strong>acromegaly.&nbsp;Pegvisomant </strong>is a<strong> growth hormone receptor antagonist</strong> used to treat this condition.</p>\n<p>Acromegaly is commonly caused due to growth hormone-secreting<strong> somatotroph adenoma. </strong>It occurs secondary to mutations of the pituitary-specific gene <strong>PIT-1. </strong></p>\n<p>Patients present with <strong>f</strong><strong>rontal bossing, i</strong><strong>ncreased hand and foot size, </strong>mandibular enlargement with <strong>prognathism, </strong>widened space between the lower incisor teeth, soft tissue swelling resulting in increased heel pad thickness, coarse facial features, and large fleshy nose.</p>\n<p>Serum<strong> IGF-1</strong> levels (elevated) and <strong>GH suppression test</strong> with oral <strong>glucose</strong> are useful in the <strong>diagnosis.</strong> The levels of GH do not reduce in response to the oral glucose load.&nbsp;</p>\n<p>Transsphenoidal surgical resection of the tumor, octreotide, and <strong>pegvisomant</strong> will be helpful in the management of this condition.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Octreotide</strong> is a synthetic <strong>analog </strong>of<strong> somatostatin</strong>. It is used for the treatment of <strong>acromegaly</strong> and <strong>secretory diarrhea.</strong></p>\n<p>Option C: <strong>Cabergoline</strong> is a dopamine <strong>D2</strong> receptor <strong>agonist.</strong> It is used as a first-line drug for the treatment of <strong>hyperprolactinemia.</strong></p>\n<p>Option D: <strong>Oglcegepant</strong> is a calcitonin gene-related peptide (<strong>CGRP</strong>) <strong>antagonist.</strong> It is used for the treatment of <strong>migraine.</strong></p><hr><h3>Related Pearl: Classification of Pituitary Adenomas with Associated Syndromes</h3><p>The various types of pituitary tumors are listed in decreasing order of frequency:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Adenoma cell origin</strong></p>\n</td>\n<td>\n<p><strong>Hormone</strong></p>\n</td>\n<td>\n<p><strong>Clinical features</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lactotroph</p>\n</td>\n<td>\n<p>Prolactin</p>\n</td>\n<td>\n<p>Galactorrhea and amenorrhea (in females)</p>\n<p>Sexual dysfunction, infertility</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gonadotroph</p>\n</td>\n<td>FSH, LH subunits</td>\n<td>\n<p>Hypogonadism, mass effects, and hypopituitarism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Somatotroph&nbsp;</p>\n</td>\n<td>\n<p>GH</p>\n</td>\n<td>\n<p>Gigantism (children)</p>\n<p>Acromegaly (adults)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Corticotroph</p>\n</td>\n<td>ACTH</td>\n<td>\n<p>Cushing's disease</p>\n<p>Nelson's syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mammosomatotroph</p>\n</td>\n<td>\n<p>Prolactin, GH</p>\n</td>\n<td>\n<p>Hypogonadism, galactorrhea, acromegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thyrotroph&nbsp;</p>\n</td>\n<td>\n<p>TSH</p>\n</td>\n<td>\n<p>Hyperthyroidism</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>GH: Growth hormone</p>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone</p>\n<p>TSH:&nbsp;Thyroid-stimulating hormone</p>\n<p>FSH:&nbsp;Follicle-stimulating hormone</p>\n<p>LH:&nbsp;Luteinizing hormone&nbsp;</p><hr><h3>Related Pearl: Tests for Acromegaly</h3><p><strong>Screening test</strong>:</p>\n<p>The <strong>single</strong>&nbsp;best test for the diagnosis of acromegaly is the measurement of serum insulin-like growth factor-1 (<strong>IGF-1</strong>). A normal serum IGF-1 concentration is strong evidence that the patient does&nbsp;<strong>not</strong>&nbsp;have acromegaly.</p>\n<p><strong>Confirmatory test</strong>:</p>\n<p>GH suppression test:<strong>&nbsp;75 g</strong> of <strong>oral glucose</strong> (OGTT- oral glucose tolerance test) is administered to the patient. Blood GH levels are checked at 30, 60, 90, 120 min (i.e over 2 hours) after the glucose load.&nbsp;Normally, glucose suppresses GH and it falls to &lt;1 ng/mL. If GH <strong>&gt;1 ng/mL</strong>, it is diagnostic of acromegaly.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5250",
      "difficulty": "medium"
    },
    {
      "text": "A diabetic patient presented with rhinitis and facial swelling. An intranasal biopsy revealed the presence of broad-based aseptate hyphae with branching at right angle. Evidence of vascular invasion was present.  What will be the drug of choice for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Fluconazole"
        },
        {
          "id": 2,
          "text": "Amphotericin B"
        },
        {
          "id": 3,
          "text": "Ketoconazole"
        },
        {
          "id": 4,
          "text": "Griseofulvin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The above scenario and biopsy findings showing <strong>broad-based</strong> <strong>aseptate hyphae</strong> with branching at <strong>right angles</strong> are suggestive of <strong>mucormycosis</strong>. The drug of choice for mucormycosis is <strong>amphotericin</strong> <strong>B</strong>.</p>\n<p>Mucormycosis is an <strong>opportunistic mycosis.</strong> It is typically seen in patients with diabetes mellitus and/or diabetic ketoacidosis and invades blood vessels.</p>\n<p>The <strong>rhino-orbital-cerebral</strong> is the most common form of mucormycosis. Patients present with <strong>rhinitis</strong>, eye or <strong>facial</strong> <strong>pain,</strong> and <strong>facial</strong> <strong>numbness</strong> followed by the onset of <strong>conjunctival</strong> <strong>suffusion</strong> and swelling along with <strong>blurry vision.</strong></p>\n<p>Diagnosis is made by <strong>biopsy</strong> with histopathologic examination. The biopsy shows characteristic wide, ribbon-like aseptate hyphal elements that branch at <strong>right angles.</strong></p>\n<p><span data-preserver-spaces=\"true\"><span class=\"s1\">The below image shows biopsy findings seen in mucormycosis.</span></span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d2ce95171f29405e8b920760512c5d76x800x600.JPEG\" alt=\"Explanation Image\"><div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>Treatment of the infection includes 4 steps:</p>\n<ol>\n<li>Initiation of therapy <strong>(amphotericin</strong> <strong>B</strong>) as early as possible.</li>\n<li><strong>Surgical</strong> debridement.</li>\n<li><strong>Reversal</strong> of underlying conditions and <strong>risk factors.</strong></li>\n<li><strong>Treatment</strong> of underlying <strong>malignancy</strong> if present.</li>\n</ol>\n<p><strong>Amphotericin B</strong>&nbsp;binds to <strong>ergosterol</strong> in the fungal membrane and forms <strong>pores or channels</strong> in the<strong> fungal cell membrane</strong>. This allows the leakage of cytosolic molecules and ions, leading to a loss of membrane integrity.</p>\n<p>It is a <strong>broad-spectrum antifungal</strong> that can be used against<em> Candida albicans, Cryptococcus neoformans, Blastomyces dermatitidis, Histoplasma capsulatum, Sporothrix schenckii,&nbsp;</em><em>Coccidioides immitis, Aspergillus.</em></p>\n<p><strong>Amphotericin B</strong> also has <strong>antiprotozoal</strong> action along with antifungal properties and is effective against <strong><em>Leishmania.</em></strong></p>\n<p><strong>Adverse effects</strong> of amphotericin B:</p>\n<ul>\n<li>Infusion-related fever and chills</li>\n<li><strong>Azotemia/nephrotoxicity</strong>- all lipid formulations of amphotericin B are less nephrotoxic than conventional amphotericin B</li>\n<li><strong>Renal tubular acidosis&nbsp;</strong></li>\n<li>Renal wasting of potassium and magnesium</li>\n<li>Hypochromic normocytic anemia- due to decreased erythropoietin production from the kidney</li>\n</ul>\n<p>Note: Mucormycosis recently emerged as an important <strong>superinfection</strong> in <strong>COVID-19</strong> patients, especially in India. The surge in cases is most likely due to diabetes mellitus and steroid use.</p>\n<p>Other options:</p>\n<p><span data-preserver-spaces=\"true\"><span class=\"s1\">Option A: <strong>Fluconazole </strong>is used for the treatment of <strong>candidiasis</strong>&nbsp;and cryptococcosis.<br /></span></span></p>\n<p><span data-preserver-spaces=\"true\"><span class=\"s1\">Option C: <strong>Ketoconazole </strong>is used for both <strong>dermatophytosis</strong> and deep mycosis, but it has been replaced by <strong>itraconazole</strong>.<br /></span></span></p>\n<p><span data-preserver-spaces=\"true\"><span class=\"s1\">Option D: <strong>Griseofulvin</strong></span></span> is used for <strong>dermatophytosis.</strong> It is effective against the mycotic disease of the skin, hair, and nails due to <em>Microsporum, Trichophyton,</em> and <em>Epidermophyton.</em></p>\n</div>\n</div><hr><h3>Related Pearl: Mechanism of action of Antifungal drugs</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e48d5ad74a9b48c6baa33c90914e13cbx1280x2560.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Classification of fungus based on morphology</h3><p>Fungi are classified into 4 types based on their morphology:</p>\n<ul>\n<li>Yeast</li>\n<li>Yeast-like</li>\n<li>Molds</li>\n<li>Dimorphic fungi</li>\n</ul>\n<p><strong>Yeast:</strong></p>\n<ul>\n<li>Unicellular fungi</li>\n<li>Reproduces by budding</li>\n<li>Oval to round forms</li>\n<li>Example: Cryptococcus,&nbsp;Saccharomyces.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0f583d17fa494e93b42864de8e82507cx597x599.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Yeast like:</strong></p>\n<ul>\n<li>Unicellular fungi</li>\n<li>Reproduces by budding or binary fission</li>\n<li>Spherical or oval forms</li>\n<li>Pseudohyphae may be seen.</li>\n<li>Example: Candida,&nbsp;Malassezia furfur.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bf7e12378e26462194d6b6f9155af000x800x501.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Molds/filamentous fungi:</strong></p>\n<ul>\n<li>Have hyphae which may be septate or aseptate</li>\n<li>Aseptate or coenocytic hyphae &ndash; Rhizopus, mucor,&nbsp;Lichtheimia.</li>\n<li>Septate hyphae &ndash; Penicillium, Dermatophytes, Aspergillus, fusarium.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/129499f438c04855bf91806ab6191d23x800x547.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Dimorphic fungi</strong></p>\n<ul>\n<li>Filamentous forms in the culture at 22<sup>0</sup>C &ndash; 25<sup>0</sup>C and in the environment.</li>\n<li>Yeast form in the culture at 37<sup>0</sup>C and in tissues.</li>\n<li>Examples &ndash; Histoplasma capsulatum, Blastomyces dermatitidis, Coccidioides immitis, Paracoccidioides brasiliensis, Talaromyces&nbsp;marneffei, Sporothrix schenckii.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5319",
      "difficulty": "easy"
    },
    {
      "text": "A tuberculosis patient on anti-tubercular treatment presents with a tingling sensation and paresthesia in the lower limbs. He is not a diabetic and occasionally consumes alcohol. Which of the following vitamins must be supplemented to this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin B6"
        },
        {
          "id": 2,
          "text": "Vitamin B12"
        },
        {
          "id": 3,
          "text": "Vitamin B2"
        },
        {
          "id": 4,
          "text": "Vitamin B3"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Vitamin B6</strong> must be supplemented for this patient. The clinical features of <strong>tingling sensation</strong> and <strong>paresthesias</strong> in a patient on anti-tubercular treatment are suggestive of the adverse effect of <strong>isoniazid</strong>.</p>\n<p><strong>Isoniazid</strong> is the first-line antitubercular drug that inhibits the production of <strong>mycolic acid</strong>. It is a bactericidal drug against tubercle bacilli.</p>\n<p>Adverse effects of isoniazid:</p>\n<ul>\n<li><strong>Peripheral neuritis </strong>(<strong>paresthesias</strong>, numbness, <strong>tingling sensation</strong>) due to interference with the production of active coenzyme pyridoxal phosphate from pyridoxine. Therefore, <strong>pyridoxine 10 mg/day (vitamin B6)</strong> is given prophylactically along with isoniazid to prevent neurotoxicity.</li>\n<li><strong>Hepatitis</strong> - isoniazid must be stopped at the first sign of hepatotoxicity.</li>\n<li>Rashes</li>\n<li>Anemia</li>\n<li>Arthralgia</li>\n</ul>\n<p>Toxicity of isoniazid results in <strong>metabolic acidosis</strong> and <strong>seizures</strong>.&nbsp;</p>\n<p>Note: Vitamin deficiency in alcoholics includes the following:</p>\n<ul>\n<li><strong>Folate</strong> causes megaloblastic anemia. It is treated by supplementation of oral doses of 5-15 mg of folic acid.</li>\n<li><strong>Vitamin B6</strong> results in peripheral neuritis, anemia, and glossitis, and lowers the seizure threshold. It is treated by supplementation of oral doses of 2-5 mg of pyridoxine.</li>\n<li><strong>Thiamine</strong> results in Wernicke's encephalopathy. It is treated with 200 mg of intravenous thiamine three times daily, followed by 10 mg/day until complete recovery.</li>\n<li><strong>Vitamin</strong> <strong>A</strong> results in xerophthalmia and night blindness. It is treated with supplementation of oral vitamin A 3000-5000 IU/day.</li>\n</ul><hr><h3>Related Pearl: Key points on the first line drugs used in the treatment of TB</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Drugs</strong></span></td>\n<td><span><strong>Isoniazid</strong></span></td>\n<td><span><strong>Rifamycins</strong></span></td>\n<td><span><strong>Pyrazinamide</strong></span></td>\n<td><span><strong>Ethambutol</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Mechanism of action</strong></span></td>\n<td>\n<p><span>Bactericidal</span></p>\n<p><span>Blocks mycolic acid synthesis.</span></p>\n</td>\n<td>\n<p><span>Bactericidal (maximum)</span></p>\n<p><span>Inhibition of RNA polymerase, leading to the inhibition of RNA synthesis.</span></p>\n</td>\n<td>\n<p><span>Bactericidal</span></p>\n<p><span>Inhibition of fatty acid synthase-I, leading to the inhibition of the cell membrane.</span></p>\n</td>\n<td>\n<p><span><strong>Bacteriostatic</strong></span></p>\n<p><span>Inhibition of arabinosyl transferase, leading to a reduction in arabinogalactan needed for the cell wall.</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Location of Mycobacteria</strong></span></td>\n<td><span>Intracellular +&nbsp; Extracellular</span></td>\n<td><span>Intracellular +&nbsp; Extracellular</span></td>\n<td><span>&nbsp;Intracellular</span></td>\n<td>&nbsp;<span>Extracellular</span></td>\n</tr>\n<tr>\n<td><span><strong>Metabolism</strong></span></td>\n<td><span>Liver&nbsp;</span></td>\n<td><span>Liver (maximum)</span></td>\n<td><span>&nbsp;Liver</span></td>\n<td>&nbsp;<span>Kidney</span></td>\n</tr>\n<tr>\n<td><span><strong>Unique side effects</strong></span></td>\n<td>\n<p><span>Shoulder hand syndrome and CNS side effects.</span></p>\n</td>\n<td><span>Orange urine, sweat, and tears. Flu-like symptoms with intermittent dosing.</span></td>\n<td>\n<p><span>The most hepatotoxic drug. It also causes hyperuricemia.</span></p>\n</td>\n<td>\n<p><span>Optic neuritis and hence, not preferred in children.</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Mechanism of resistance</strong></span></td>\n<td>\n<p><span>Kat G mutation- the most severe form of resistance.</span></p>\n<p><span>Inh a gene overexpression-&nbsp; confers cross-resistance with ethionamide.</span></p>\n</td>\n<td>\n<p class=\"p1\"><span>Mutation in <em>rpoB-</em>&nbsp;the gene coding for the <span class=\"s1\">&beta; </span>subunit of RNA polymerase.</span></p>\n</td>\n<td><span>Mutation of the&nbsp;<em>Pnca</em> gene.</span></td>\n<td>\n<p class=\"p1\"><span>Mutations in the <em>embB</em> gene.</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: General properties of the first line drugs in TB</h3><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>First-line drugs</strong></span></div>\n</td>\n<td>\n<div><span><strong>Isoniazid</strong></span></div>\n</td>\n<td>\n<div><span><strong>Rifampicin</strong></span></div>\n</td>\n<td>\n<div><span><strong>Pyrazinamide</strong></span></div>\n</td>\n<td>\n<div><span><strong>Ethambutol</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Mechanism</strong></span></div>\n</td>\n<td>\n<div><span>Bactericidal</span></div>\n</td>\n<td>\n<div><span>Bactericidal</span></div>\n<div><span>(Maximum)</span></div>\n</td>\n<td>\n<div><span>Bactericidal</span></div>\n</td>\n<td>\n<div><span>Bacteriostatic</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Location of Mycobacteria</strong></span></div>\n</td>\n<td>\n<div><span>Intracellular +&nbsp; Extracellular</span></div>\n</td>\n<td>\n<div><span>Intracellular +&nbsp; Extracellular</span></div>\n</td>\n<td>\n<div><span>Intracellular</span></div>\n</td>\n<td>\n<div><span>Extracellular</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Metabolism</strong></span></div>\n</td>\n<td>\n<div><span>Liver</span></div>\n</td>\n<td>\n<div><span>Liver</span></div>\n<div><span>(Maximum)</span></div>\n</td>\n<td>\n<div><span>Liver</span></div>\n</td>\n<td>\n<div><span>Kidney</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5195",
      "difficulty": "easy"
    },
    {
      "text": "An elderly woman received a botox injection for the treatment of wrinkles. Which of the following is the mechanism of action of botulinum toxin?",
      "choices": [
        {
          "id": 1,
          "text": "Inhibits the release of acetylcholine"
        },
        {
          "id": 2,
          "text": "Release of noradrenaline at synaptic cleft"
        },
        {
          "id": 3,
          "text": "Selectively and irreversibly inhibits nicotinic receptors"
        },
        {
          "id": 4,
          "text": "Stimulates muscarinic and nicotinic receptors"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The<strong> botulinum toxin</strong> acts by<strong> inhibiting</strong> the<strong> release</strong> of<strong> acetylcholine</strong>&nbsp;into the synaptic cleft.</p>\n<p>Botulinum toxin <strong>cleaves SNARE</strong> protein, which is involved in the exocytosis of acetylcholine. Thus, it inhibits the release of acetylcholine.</p>\n<p>The image given below shows the site of action of botulinum toxin:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/679a402efdee47c7b4fd3adaa70f4af1x1280x2234.JPEG\" alt=\"Explanation Image\"><p>This toxin causes a long-lasting loss of cholinergic transmission. Hence, it can be employed for the treatment of several spastic and neurological conditions caused by the overactivity of cholinergic nerves, such as&nbsp;<strong>age-related facial wrinkles,&nbsp;</strong>blepharospasm, <strong>spastic cerebral palsy</strong>, spasmodic torticollis<strong>, post-stroke spasticity</strong>, and axillary hyperhidrosis.</p>\n<p>Adverse effects occur due to incorrect injection and overdose; they include <strong>ptosis, </strong>diplopia, facial swelling, dry mouth, <strong>muscle weakness,</strong> and<strong> respiratory paralysis.</strong></p>\n<p>Botulinum toxin is an <strong>exotoxin</strong> produced by the bacteria <em>Clostridium botulinum</em>. It is responsible for a type of food poisoning called <strong>botulism</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5189",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is a PCSK9 inhibitor?",
      "choices": [
        {
          "id": 1,
          "text": "Evolocumab"
        },
        {
          "id": 2,
          "text": "Ezetimibe"
        },
        {
          "id": 3,
          "text": "Bempedoic acid"
        },
        {
          "id": 4,
          "text": "Clofibrate"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Evolocumab</strong> is a <strong>PCSK9</strong> inhibitor.</p>\n<p>PCSK9 refers to <span class=\"ILfuVd\" lang=\"en\"><span class=\"hgKElc\"><strong>proprotein convertase subtilisin/kexin type 9</strong></span></span>. They are mainly involved in the downregulation of low-density lipoprotein (<strong>LDL</strong>) receptors in the liver.</p>\n<p><strong>Evolocumab</strong> is a monoclonal antibody that inhibits<strong> PCSK-9&nbsp;</strong>(proprotein convertase subtilisin/kexin). Inhibition of PCSK-9 prevents the degradation of LDL receptors and thus <strong>increases LDL-cholesterol clearance</strong> by the <strong>liver</strong>. They are used in patients with atherosclerotic cardiovascular disease (<strong>ASCVD</strong>) to decrease LDL levels.</p>\n<p>Side effects of PCSK9 inhibitors are <strong>i</strong><strong>njection-site reactions, </strong>nasopharyngitis, urinary tract infection, and upper respiratory tract infection and it does <strong>not</strong> increase the risk of <strong>myopathy</strong>.&nbsp;</p>\n<p>Other options:</p>\n<p>Option B: <strong>Ezetimibe</strong> inhibits cholesterol <strong>absorption</strong> by enterocytes in the small intestine. It lowers the total and LDL-C levels.</p>\n<p>Option C: <strong>Bempedoic acid</strong> <span class=\"ILfuVd\" lang=\"en\"><span class=\"hgKElc\">inhibits adenosine triphosphate-<span tabindex=\"0\" role=\"tooltip\"><span class=\"povykd\" tabindex=\"0\" role=\"button\" data-enable-toggle-animation=\"true\" data-extra-container-classes=\"ZLo7Eb\" data-hover-hide-delay=\"1000\" data-hover-open-delay=\"500\" data-send-open-event=\"true\" data-theme=\"0\" data-width=\"250\" data-ved=\"2ahUKEwiM5bPV9dD4AhUO9zgGHe8oCMIQmpgGegQIBRAD\"><span class=\"JPfdse\" data-bubble-link=\"\" data-segment-text=\"citrate lyase\">citrate lyase</span></span></span> (ACL) and results in <strong>decreased LDL </strong>in patients not responding to statin therapy. <br /></span></span></p>\n<p>Option D: <strong>Clofibrate</strong> binds to <strong>PPAR-alpha</strong> and causes stimulation of fatty acid oxidation and increased LPL synthesis. This results in reduced triglycerides, LDL and increased high-density lipoprotein (HDL) levels. It causes <strong>myopathy</strong> when combined with statins and is associated with an increased risk of <strong>gallstone</strong> formation.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5146",
      "difficulty": "medium"
    },
    {
      "text": "An elderly man presents with rigidity and tremors. On examination, he has blank facial expressions. Which of the following drugs can be used to manage this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Clozapine"
        },
        {
          "id": 2,
          "text": "Donepezil"
        },
        {
          "id": 3,
          "text": "Selegiline"
        },
        {
          "id": 4,
          "text": "Haloperidol"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical features of <strong>rigidity, tremors,</strong>&nbsp;and <strong>blank facial expressions</strong> are suggestive of <strong>Parkinson's disease</strong>. Monoamine oxidase-B (<strong>MAO-B</strong>) <strong>inhibitors</strong> like <strong>selegiline</strong> are used for the treatment of Parkinson disease.</p>\n<p>Normally, MAO-B oxidizes dopamine. Selegiline is a selective and irreversible MAO-B inhibitor. Therefore, it&nbsp;<strong>increases dopamine</strong> levels in the brain. It is used as an <strong>adjuvant</strong> to <strong>levodopa</strong> in Parkinson's disease. It prolongs and enhances the action of levodopa.</p>\n<p>Adverse effects of selegiline are <strong>postural hypotension, </strong>nausea, confusion, involuntary movements, and <strong>psychosis. </strong>Selegiline is <strong>contraindicated</strong> in patients with <strong>convulsive</strong> disorders.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Clozapine </strong>is an atypical antipsychotic that selectively <strong>blocks</strong> dopamine (<strong>D4</strong>) receptors in the brain. It is used in the treatment of&nbsp;<strong>refractory schizophrenia</strong>. <strong>Agranulocytosis</strong> and <strong>metabolic syndrome</strong> are the important <strong>adverse effects.</strong></p>\n<p>Option B: <strong>Donepezil</strong> is a reversible <strong>cholinesterase inhibitor</strong> used for the treatment of <strong>Alzheimer's disease</strong>.</p>\n<p>Option D: <strong>Haloperidol </strong>is a <strong>typical antipsychotic</strong> used for the treatment of <strong>acute schizophrenia</strong>, Huntington&rsquo;s disease, and Gilles de la Tourette syndrome.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5188",
      "difficulty": "medium"
    }
  ]
}